IDH2 and acute promyelocytic leukemia: Similarly to APL patients, patients with co-occurring NPM1 and IDH2R140 mutations, but not other IDH variants, also showed markedly elevated MALNC expression (Fig. 3E; Supplementary Fig. 5C, D; 6A–C).